Too much water drowned the miller: Akkermansia determines immunotherapy responses

Le Li; Florencia McAllister

doi:10.1016/j.xcrm.2022.100642

Too much water drowned the miller: Akkermansia determines immunotherapy responses

Le Li, Florencia McAllister

Clinical Cancer Prevention

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Abstract

Derosa et al.¹ demonstrated that intestinal Akkermansia muciniphila predicts vigorous response to immunotherapy in non-small-cell lung cancer. Baseline level of this microbe has better value than PD-L1 expression and represents a unique approach for stratifying patients that can benefit from immunotherapy.

Original language	English (US)
Article number	100642
Journal	Cell Reports Medicine
Volume	3
Issue number	5
DOIs	https://doi.org/10.1016/j.xcrm.2022.100642
State	Published - May 17 2022

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology
General Medicine

Access to Document

10.1016/j.xcrm.2022.100642

Cite this

@article{45656fadb6da4d8184b5a2cedc964a2b,

title = "Too much water drowned the miller: Akkermansia determines immunotherapy responses",

abstract = "Derosa et al.1 demonstrated that intestinal Akkermansia muciniphila predicts vigorous response to immunotherapy in non-small-cell lung cancer. Baseline level of this microbe has better value than PD-L1 expression and represents a unique approach for stratifying patients that can benefit from immunotherapy.",

author = "Le Li and Florencia McAllister",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = may,

day = "17",

doi = "10.1016/j.xcrm.2022.100642",

language = "English (US)",

volume = "3",

journal = "Cell Reports Medicine",

issn = "2666-3791",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Too much water drowned the miller

T2 - Akkermansia determines immunotherapy responses

AU - Li, Le

AU - McAllister, Florencia

PY - 2022/5/17

Y1 - 2022/5/17

N2 - Derosa et al.1 demonstrated that intestinal Akkermansia muciniphila predicts vigorous response to immunotherapy in non-small-cell lung cancer. Baseline level of this microbe has better value than PD-L1 expression and represents a unique approach for stratifying patients that can benefit from immunotherapy.

AB - Derosa et al.1 demonstrated that intestinal Akkermansia muciniphila predicts vigorous response to immunotherapy in non-small-cell lung cancer. Baseline level of this microbe has better value than PD-L1 expression and represents a unique approach for stratifying patients that can benefit from immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85130203082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130203082&partnerID=8YFLogxK

U2 - 10.1016/j.xcrm.2022.100642

DO - 10.1016/j.xcrm.2022.100642

M3 - Comment/debate

C2 - 35584634

AN - SCOPUS:85130203082

SN - 2666-3791

VL - 3

JO - Cell Reports Medicine

JF - Cell Reports Medicine

IS - 5

M1 - 100642

ER -

Too much water drowned the miller: Akkermansia determines immunotherapy responses

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this